Relative lack of systemic efforts in clinical dissection of interactions between hypertension and COVID-19 is surprising, especially in light of an active involvement of ACE2, a receptor for SARS-CoV-2, in the hypertension control (Verano-Braga et al., 2020). Here, ACE2 is linked to Hypertension.